With the right approach, though, GLP-1s can be a game-changer
Study sizes are frequently small, endpoints vary, and results are inconsistent across routes of administration
Flint J, Kendler KS
Under the supervision of a Houston doctor, these targeted medications interact with your brain to signal fullness, slow digestion, and quiet the food noise. By addressing the root chemical imbalances of insulin resistance and hunger, GLP-1 medications level the playing field
Were thrilled to be sharing new data from the proof-of-concept clinical study of NG101, our oral candidate to reduce nausea and vomiting induced by GLP-1 agonists
Understanding this evolving research area is important for clinicians managing patients with both metabolic conditions and substance use history